A detailed history of Talbot Financial, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Talbot Financial, LLC holds 138,104 shares of NVO stock, worth $6.69 Million. This represents 0.65% of its overall portfolio holdings.

Number of Shares
138,104
Previous 124,973 10.51%
Holding current value
$6.69 Million
Previous $8.63 Billion 11.16%
% of portfolio
0.65%
Previous 0.82%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 08, 2025

BUY
$45.38 - $71.7 $595,884 - $941,492
13,131 Added 10.51%
138,104 $7.66 Billion
Q2 2025

Jul 21, 2025

BUY
$58.08 - $81.05 $1.34 Million - $1.87 Million
23,133 Added 22.72%
124,973 $8.63 Billion
Q1 2025

Apr 09, 2025

BUY
$69.3 - $90.95 $3.78 Million - $4.96 Million
54,574 Added 115.46%
101,840 $7.07 Billion
Q4 2024

Jan 13, 2025

BUY
$85.0 - $120.04 $4.02 Million - $5.67 Million
47,266 New
47,266 $4.07 Billion

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $109B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Talbot Financial, LLC Portfolio

Follow Talbot Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Talbot Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Talbot Financial, LLC with notifications on news.